ArticleLasers in medical science2025
Classification of disease subtypes in medical spectroscopy for multi-category sample imbalances based on grouping and hierarchical learning.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration.Molecules (Basel, Switzerland) · 2026Review
- A hybrid model integrating RoBERTa, TF-IDF, and attention mechanism for medical query intent classification.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In the medical domain, the challenges in sample acquisition and collection often result in imbalanced training sets for multi-class models, especially in disease subtype differentiation. We propose a novel method to address multi-class imbalance in serum Raman spectroscopy data for disease subtyping. We address multi-class imbalance by grouping samples according to their noise levels and employing hierarchical incremental learning, which balances the training data and mitigates the noise introduced by augmentation, thus improving the model's accuracy in distinguishing similar disease subtypes. We collected imbalanced serum Raman spectroscopy data from two hepatitis subtypes and a control group, comparing the performance of Convolutional Neural Network (CNN) and Random Forest (RF) models using both original and augmented data, where the augmented data was identical to the training data used in our model. The results show that the proposed method effectively subtypes similar disease subtypes under sample imbalance, particularly for those with limited sample sizes. Our approach achieves an accuracy and F1 score both exceeding 95% on the hepatitis data. However, its broader applicability and potential will require further investigation and validation. All the code is available at https://github.com/RuiGao-1223/GHIL .
Indexed as
Identifiers
40387978What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.